Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062993-13-002828
Filing Date
2013-05-30
Accepted
2013-05-30 11:24:03
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F/A form20fa.htm 20-F/A 11439
  Complete submission text file 0001062993-13-002828.txt   15165598

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE ssrs-20121231.xml EX-101.INS 1759567
3 XBRL SCHEMA FILE ssrs-20121231.xsd EX-101.SCH 439762
4 XBRL CALCULATION FILE ssrs-20121231_cal.xml EX-101.CAL 79649
5 XBRL DEFINITION FILE ssrs-20121231_def.xml EX-101.DEF 1033670
6 XBRL LABEL FILE ssrs-20121231_lab.xml EX-101.LAB 2866126
7 XBRL PRESENTATION FILE ssrs-20121231_pre.xml EX-101.PRE 1150605
Mailing Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027
Business Address NO.3 A1, ROAD 10 SHENYANG ECONOMY & TECHNOLOGY DEVELOPMENT ZONE SHENYANG F4 110027 86-24-2581-1820
3SBio Inc. (Filer) CIK: 0001383790 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-33295 | Film No.: 13880382
SIC: 2834 Pharmaceutical Preparations